Experimental cancer injection tested in small safety trial
Disease control
Terminated
This early-stage study tested a new drug called RiMO-401, injected directly into tumors along with radiation therapy, for people with advanced cancers. The main goal was to find a safe dose and check for side effects in a small group of 5 participants. The study was terminated ea…
Phase: PHASE1 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC